These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 17395167)

  • 1. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.
    Butterfield DA; Reed TT; Perluigi M; De Marco C; Coccia R; Keller JN; Markesbery WR; Sultana R
    Brain Res; 2007 May; 1148():243-8. PubMed ID: 17395167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    J Cell Mol Med; 2008 Jun; 12(3):987-94. PubMed ID: 18494939
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease.
    Cenini G; Sultana R; Memo M; Butterfield DA
    Free Radic Biol Med; 2008 Jul; 45(1):81-5. PubMed ID: 18439434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteomic identification of nitrated brain proteins in amnestic mild cognitive impairment: a regional study.
    Sultana R; Reed T; Perluigi M; Coccia R; Pierce WM; Butterfield DA
    J Cell Mol Med; 2007; 11(4):839-51. PubMed ID: 17760844
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of mTOR signaling occurs early in the progression of Alzheimer disease (AD): analysis of brain from subjects with pre-clinical AD, amnestic mild cognitive impairment and late-stage AD.
    Tramutola A; Triplett JC; Di Domenico F; Niedowicz DM; Murphy MP; Coccia R; Perluigi M; Butterfield DA
    J Neurochem; 2015 Jun; 133(5):739-49. PubMed ID: 25645581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomics-determined differences in the concanavalin-A-fractionated proteome of hippocampus and inferior parietal lobule in subjects with Alzheimer's disease and mild cognitive impairment: implications for progression of AD.
    Owen JB; Di Domenico F; Sultana R; Perluigi M; Cini C; Pierce WM; Butterfield DA
    J Proteome Res; 2009 Feb; 8(2):471-82. PubMed ID: 19072283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The wheat germ agglutinin-fractionated proteome of subjects with Alzheimer's disease and mild cognitive impairment hippocampus and inferior parietal lobule: Implications for disease pathogenesis and progression.
    Di Domenico F; Owen JB; Sultana R; Sowell RA; Perluigi M; Cini C; Cai J; Pierce WM; Butterfield DA
    J Neurosci Res; 2010 Dec; 88(16):3566-77. PubMed ID: 20936705
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative and nitrosative modifications of biliverdin reductase-A in the brain of subjects with Alzheimer's disease and amnestic mild cognitive impairment.
    Barone E; Di Domenico F; Cenini G; Sultana R; Coccia R; Preziosi P; Perluigi M; Mancuso C; Butterfield DA
    J Alzheimers Dis; 2011; 25(4):623-33. PubMed ID: 21483094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence of increased oxidative damage in subjects with mild cognitive impairment.
    Keller JN; Schmitt FA; Scheff SW; Ding Q; Chen Q; Butterfield DA; Markesbery WR
    Neurology; 2005 Apr; 64(7):1152-6. PubMed ID: 15824339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redox proteomics analysis of brains from subjects with amnestic mild cognitive impairment compared to brains from subjects with preclinical Alzheimer's disease: insights into memory loss in MCI.
    Aluise CD; Robinson RA; Cai J; Pierce WM; Markesbery WR; Butterfield DA
    J Alzheimers Dis; 2011; 23(2):257-69. PubMed ID: 20930294
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.
    Peng S; Wuu J; Mufson EJ; Fahnestock M
    J Neurochem; 2005 Jun; 93(6):1412-21. PubMed ID: 15935057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redox proteomics identification of oxidatively modified hippocampal proteins in mild cognitive impairment: insights into the development of Alzheimer's disease.
    Butterfield DA; Poon HF; St Clair D; Keller JN; Pierce WM; Klein JB; Markesbery WR
    Neurobiol Dis; 2006 May; 22(2):223-32. PubMed ID: 16466929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic identification of nitrated brain proteins in early Alzheimer's disease inferior parietal lobule.
    Reed TT; Pierce WM; Turner DM; Markesbery WR; Allan Butterfield D
    J Cell Mol Med; 2009 Aug; 13(8B):2019-2029. PubMed ID: 18752637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hippocampal metabolic abnormalities in mild cognitive impairment and Alzheimer's disease.
    Ackl N; Ising M; Schreiber YA; Atiya M; Sonntag A; Auer DP
    Neurosci Lett; 2005 Aug 12-19; 384(1-2):23-8. PubMed ID: 15905028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment.
    Markesbery WR; Kryscio RJ; Lovell MA; Morrow JD
    Ann Neurol; 2005 Nov; 58(5):730-5. PubMed ID: 16240347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regional expression of key cell cycle proteins in brain from subjects with amnestic mild cognitive impairment.
    Sultana R; Butterfield DA
    Neurochem Res; 2007; 32(4-5):655-62. PubMed ID: 17006763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment.
    Butterfield DA; Reed T; Perluigi M; De Marco C; Coccia R; Cini C; Sultana R
    Neurosci Lett; 2006 Apr; 397(3):170-3. PubMed ID: 16413966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative damage in mild cognitive impairment and early Alzheimer's disease.
    Lovell MA; Markesbery WR
    J Neurosci Res; 2007 Nov; 85(14):3036-40. PubMed ID: 17510979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreased levels of PSD95 and two associated proteins and increased levels of BCl2 and caspase 3 in hippocampus from subjects with amnestic mild cognitive impairment: Insights into their potential roles for loss of synapses and memory, accumulation of Abeta, and neurodegeneration in a prodromal stage of Alzheimer's disease.
    Sultana R; Banks WA; Butterfield DA
    J Neurosci Res; 2010 Feb; 88(3):469-77. PubMed ID: 19774677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of phospholipid asymmetry and elevated brain apoptotic protein levels in subjects with amnestic mild cognitive impairment and Alzheimer disease.
    Bader Lange ML; Cenini G; Piroddi M; Abdul HM; Sultana R; Galli F; Memo M; Butterfield DA
    Neurobiol Dis; 2008 Mar; 29(3):456-64. PubMed ID: 18077176
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.